Physician profile
Anton Strocel
NPI 1093813180
$1,286.43
in general payments reported to CMS, 2019-2025
15 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $197 · 2021: $237 · 2023: $202 · 2024: $289 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $813.98 | 2020-2025 | Restorelle |
| Abbvie INC. | $134.87 | 2019-2021 | |
| Intuitive Surgical, INC. | $95.83 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.88 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $28.45 | 2019-2021 | |
| Zyla Life Sciences, INC. | $23.65 | 2020 | |
| Amag Pharmaceuticals, INC. | $20.27 | 2019 | |
| Therapeuticsmd, INC. | $17.68 | 2020 | |
| Mayne Pharma Commercial LLC | $17.66 | 2021 | |
| Exeltis, USA INC. | $15.98 | 2020 | |
| Coopersurgical, INC. | $15.93 | 2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $13.38 | 2023 | Aptima, Thinprep 2000 Processor |
| Boston Scientific Corporation | $13.02 | 2019 | |
| Pfizer INC. | $12.69 | 2020 | |
| Organon LLC | $8.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Strocel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.